亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Effects of commonly used chronic medications on the outcomes of ipilimumab therapy in patients with metastatic melanoma.

医学 易普利姆玛 转移性黑色素瘤 黑色素瘤 肿瘤科 内科学 重症监护医学 皮肤病科 癌症 免疫疗法 癌症研究
作者
Jarrett Failing,Heidi D. Finnes,Lisa A. Kottschade,Jacob B. Allred,Svetomir N. Markovic
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:34 (15_suppl): e21038-e21038 被引量:2
标识
DOI:10.1200/jco.2016.34.15_suppl.e21038
摘要

e21038 Background: Ipilimumab can induce long-term survival in up to 20% of patients with metastatic melanoma, however response comes with high rates of immune-related adverse events (irAEs). Concurrent chronic medications may impact the patient’s immune system, possess anti-melanoma properties, and potentially affect clinical outcomes (efficacy and/or toxicity). This retrospective study sought to describe the influence of 12 classes of concomitant chronic medications used by metastatic melanoma patients undergoing therapy with ipilimumab. Methods: Retrospective study of 159 adults who received ipilimumab for metastatic melanoma at Mayo Clinic in Rochester, MN from March 1, 2011 through December 31, 2014. Data on patient characteristics, best tumor response, irAEs, progression, death, and use of chronic medications (statins, metformin, beta blockers, ACE/ARBs, calcium channel blockers, aspirin, NSAIDs, H1 and H2 receptor antagonists, proton pump inhibitors, antidepressants, and vitamin D supplements) were abstracted from the electronic medical record. For the analysis of best tumor response and irAEs, a case-control analysis was employed. Overall survival (OS) and progression-free survival (PFS) were evaluated using the Kaplan Meier method and Cox Proportional Hazard modeling. Results: Of the 12 concomitant medication classes, only proton pump inhibitors (PPIs) were found to have an increased odds of experiencing a partial response (PR) or complete response (CR) to ipilimumab (OR, 3.73; CI 1.26-11.04; p = .02). While not significant, PPI use trended towards improved OS and PFS (HR, 0.44; CI 0.17-1.15; p = .09; and HR, 0.6; CI 0.34-1.06; p = .08; respectively). Likewise, H2 antagonist use may result in an increased odds of PR or CR (OR, 5.27; CI 0.99-28.1; p = .05). No medication class was associated with increased risk of grade 3/4 irAEs. Conclusions: Patients on PPIs may be more likely to experience a PR/CR following ipilimumab therapy. Due to the small sample size and retrospective nature of this work, these finding are only descriptive and support further study. Other classes of chronic medications did not produce statistically significant effects for any of the measured outcomes.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yindi1991完成签到 ,获得积分10
1分钟前
hgl完成签到,获得积分10
2分钟前
2分钟前
科研通AI2S应助科研通管家采纳,获得10
2分钟前
2分钟前
华仔应助精明晓刚采纳,获得10
2分钟前
3分钟前
3分钟前
精明晓刚发布了新的文献求助10
3分钟前
糖伯虎完成签到 ,获得积分10
4分钟前
在水一方应助科研通管家采纳,获得10
4分钟前
光合作用完成签到,获得积分10
4分钟前
5分钟前
精明晓刚发布了新的文献求助10
5分钟前
精明晓刚完成签到,获得积分10
5分钟前
6分钟前
搜集达人应助kangkang采纳,获得10
6分钟前
英姑应助科研通管家采纳,获得10
6分钟前
kangkang完成签到,获得积分20
6分钟前
6分钟前
刘紫媛发布了新的文献求助10
7分钟前
故意的冰淇淋完成签到 ,获得积分10
7分钟前
刘紫媛完成签到,获得积分20
7分钟前
Lucas应助Dave采纳,获得10
7分钟前
刘紫媛关注了科研通微信公众号
7分钟前
7分钟前
Akitten发布了新的文献求助10
8分钟前
草木完成签到 ,获得积分20
8分钟前
完美世界应助科研通管家采纳,获得10
8分钟前
领导范儿应助科研通管家采纳,获得10
8分钟前
Orange应助Boren采纳,获得10
8分钟前
9分钟前
Boren发布了新的文献求助10
9分钟前
大个应助Boren采纳,获得10
9分钟前
Raunio完成签到,获得积分10
9分钟前
Akitten发布了新的文献求助10
9分钟前
完美世界应助lhy采纳,获得10
10分钟前
科研通AI2S应助科研通管家采纳,获得10
10分钟前
10分钟前
10分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990351
求助须知:如何正确求助?哪些是违规求助? 3532158
关于积分的说明 11256513
捐赠科研通 3271046
什么是DOI,文献DOI怎么找? 1805207
邀请新用户注册赠送积分活动 882302
科研通“疑难数据库(出版商)”最低求助积分说明 809234